Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
14 04 2020
Historique:
received: 22 10 2019
accepted: 16 03 2020
entrez: 15 4 2020
pubmed: 15 4 2020
medline: 25 7 2020
Statut: epublish

Résumé

Female children and adults typically generate more efficacious immune responses to vaccines and infections than age-matched males, but also suffer greater immunopathology and autoimmune disease. We here describe, in a cohort of > 170 in utero HIV-infected infants from KwaZulu-Natal, South Africa, fetal immune sex differences resulting in a 1.5-2-fold increased female susceptibility to intrauterine HIV infection. Viruses transmitted to females have lower replicative capacity (p = 0.0005) and are more type I interferon-resistant (p = 0.007) than those transmitted to males. Cord blood cells from females of HIV-uninfected sex-discordant twins are more activated (p = 0.01) and more susceptible to HIV infection in vitro (p = 0.03). Sex differences in outcome include superior maintenance of aviraemia among males (p = 0.007) that is not explained by differential antiretroviral therapy adherence. These data demonstrate sex-specific innate immune selection of HIV associated with increased female susceptibility to in utero infection and enhanced functional cure potential among infected males.

Identifiants

pubmed: 32286302
doi: 10.1038/s41467-020-15632-y
pii: 10.1038/s41467-020-15632-y
pmc: PMC7156749
doi:

Substances chimiques

Anti-Retroviral Agents 0
Interferons 9008-11-1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1767

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI133673
Pays : United States
Organisme : Wellcome Trust
ID : WT 110110
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT 104748MA
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Références

Darwin, C. R. The Descent of Man and Selection in Relation to Sex (John Murray, London, 1871).
Klein, S. L. & Flanagan, K. L. Sex differences in immune responses. Nat. Rev. Immunol. 16, 626–638 (2016).
pubmed: 27546235
Flanagan, K. L., Fink, A. L., Plebanski, M. & Klein, S. L. Sex and gender differences in the outcomes of vaccination over the life course. Annu. Rev. Cell Dev. Biol. 33, 577–599 (2017).
pubmed: 28992436
Meier, A. et al. Sex differences in the TLR-mediated response of pDCs to HIV-1 are associated with higher immune activation in women. Nat. Med. 15, 955–959 (2009).
pubmed: 19597505 pmcid: 2821111
Souyris, M. et al. TLR7 escapes X chromosome inactivation in immune cells. Sci. Immunol. 3, eaaqp8855 (2018).
Gandhi, M. et al. Does patient sex affect human immunodeficiency virus levels? Clin. Infect. Dis. 35, 313–322 (2002).
pubmed: 12115098
Yang, O. O. et al. Demographics and natural history of HIV-1-infected spontaneous controllers of viremia. AIDS 31, 1091–1098 (2017).
pubmed: 28301422 pmcid: 5657480
Deeks, S. G. et al. Immune activation set-point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104, 942–947 (2004).
pubmed: 15117761
Marinda, E. et al. Child mortality according to maternal and infant status in Zimbabwe. Pediatr. Infect. Dis. J. 26, 519–526 (2007).
pubmed: 17529870
Taha, T. E. et al. Gender differences in perinatal acquisition among African infants. Pediatrics 115, e167–e172 (2005).
pubmed: 15687425
European Collaborative Study, ThorneC. & Newell, M.-L. Are girls more at risk of intrauterine-acquired HIV infection then boys? AIDS 18, 344–347 (2004).
KwaZulu-Natal Birth Registrations, http://www.statssa.gov.za/publications/P0305/P03052017.pdf (2017).
Iyer, S. S. et al. Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness. Proc. Natl Acad. Sci. USA 114, E590–E599 (2017).
Fenton-May, A. E. et al. Relative resistance of HIV-1 founder viruses to control by interferon-alpha. Retrovirology 10, 146 (2013).
pubmed: 24299076 pmcid: 3907080
European Collaborative Study. Level and pattern of HIV-1 RNA viral load over age: differences between boys and girls? AIDS 16, 97–104 (2002).
Sharaf, R. et al. HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers. J. Clin. Invest. https://doi.org/10.1172/JCI120549 (2018).
doi: 10.1172/JCI120549 pubmed: 30024859 pmcid: 6118642
Saez-Cirion, A. et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog. 9, e1003211 (2013).
pubmed: 23516360 pmcid: 3597518
Persaud, D. et al. Absence of detectable HIV-1 viremia after treatment cessation in an infant. N. Engl. J. Med. 369, 1828–1835 (2013).
pubmed: 24152233 pmcid: 3954754
Hill, M. F. et al. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: an observational study. PLoS Med. 14, e1002417 (2017).
pubmed: 29112956 pmcid: 5675377
Henrich, T. J. et al. Antiretroviral-free HIV-1 remission and viral rebound following allogeneic stem cell transplantation: a report of two cases. Ann. Int Med. 161, 319–327 (2014).
pubmed: 25047577
Colby, D. J. et al. Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection. Nat. Med. 24, 923–926 (2018).
pubmed: 29892063 pmcid: 6092240
Technau, K. G. et al. 12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort study. Lancet Hiv. 5, e706–e714 (2018).
pubmed: 30416043 pmcid: 6336389
Tibshirani, R. The lasso method for variable selection in the Cox model. Stat. Med. 16, 385–395 (1997).
pubmed: 9044528
Simon, N., Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for Cox’s proportional hazards model via coordinate descent. J. Stat. Softw. 39, 1–13 (2011).
pubmed: 4824408 pmcid: 4824408
Millar, J. et al. High-frequency failure of combination antiretroviral therapy in paediatric HIV infection is rooted in maternal non-adherence: a prospective cohort study in KwaZulu-Natal, South Africa. In review.
European Paediatric Hepatitis C Virus Network. A significant sex—but not elective cesarean section—effect on mother-to-child transmission of hepatitis C virus infection. J. Infect. Dis. 192, 1872–1879 (2005).
Mast, E. E. et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J. Infect. Dis. 192, 1880–1889 (2005).
pubmed: 16267758
Watt, A. P., Loughlin, L. & Coyle, P. V. Congenital CMV disease—a female bias in Northern Ireland? J. Clin. Virol. 77, 99–100 (2016).
pubmed: 26921742
Ruel, T. D. et al. Sex differences in HIV RNA level and CD4 cell percentage during childhood. Clin. Infect. Dis. 53, 592–599 (2011).
pubmed: 21840929 pmcid: 3160805
Leitman, E. M. et al. Role of HIV-specific CD8+ T-cells in paediatric HIV cure strategies following widespread early viral escape. J. Exp. Med 214, 3239–3261 (2017).
pubmed: 28983013 pmcid: 5679167
Vieira, V. et al. Strong sex bias in elite control of paediatric HIV infection. AIDS 33, 67–75 (2019).
pubmed: 30325765
Ostrowski, M. A. et al. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J. Immunol. 161, 3195–3201 (1998).
pubmed: 9743388
Claiborne, D. T. et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T-cells and disease progression. Proc Nat Acad Sci USA. 112, E1480-E1489 (2015).
Violari, A. et al. A child with perinatal HIV infection and long-term virological control following antiretroviral treatment cessation. Nat. Commun. 10, 412 (2019).
pubmed: 30679439 pmcid: 6345921
Tomlinson, C., Macintyre, H., Dorrian, C. A., Ahmed, S. F. & Wallace, A. M. Testosterone measurements in early infancy. Arch. Dis. Child Fetal Neonatal Ed. 89, 558–559 (2004).
Griesbeck, M. et al. Sex differences in plasmacytoid dendritic cells levels of IRF5 drive higher IFN-α production in women. J. Immunol. 195, 5327–5336 (2015).
pubmed: 26519527 pmcid: 4654231
Furman, D. et al. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc. Natl Acad. Sci. 111, 869–874 (2014).
pubmed: 24367114
Suderman, M. et al. Sex-associated autosomal DNA methylation differences are wide-spread and stable throughout childhood. Biorxiv. 118265 https://doi.org/10.1101/118265 (2017).
Sandler, N. G. et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 511, 601–605 (2014).
pubmed: 25043006 pmcid: 4418221
Deymier, M. J. et al. Heterosexual transmission of subtype C HIV-1 selects consensus-like variants without increased replicative capacity or interferon-a resistance. PLoS Pathog. 11, e1005154 (2015).
pubmed: 26378795 pmcid: 4574710
Ansari, A. M. et al. Interferon lambda 4 impacts the genetic diversity of hepatitis C virus. eLife 8, e42463 (2019).
pubmed: 31478835 pmcid: 6721795
Carlson, J. et al. HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck. Science 345, 1254031 (2014).
pubmed: 25013080 pmcid: 4289910
Abdool Karim, Q. et al. Prevention of HIV in adolescent girls and young women: key to an AIDS-free generation. J. Acquir Immune Defic. Syndr. 75, S17–S26 (2017).
pubmed: 28398993
De Oliveira, T. et al. Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study. Lancet HIV 4, e41–e50 (2017).
pubmed: 27914874
Duneau, D. & Ebert, D. Host sexual dimorphism and parasite adaptation. PLoS Biol. 10, e1001271 (2012).
pubmed: 22389630 pmcid: 3289593
Guindon, S., Lethiec, F., Duroux, P. & Gascuel, O. PhyML: PHYML Online—a web server for fast maximum likelihood-based phylogenetic inference. Nucleic Acids Res. 33, W557–W559 (2005).
pubmed: 15980534 pmcid: 1160113
Drummond, A. J., Suchard, M. A., Xie, D. & Rambaut, A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol. Biol. Evol. 29, 1969–1973 (2012).
pubmed: 22367748 pmcid: 3408070
Reed, L. J. & Muench, H. A simple method of estimating fifty per cent endpoint. Am. J. Hyg. 27, 493–497 (1938).
Buzón, M. J. et al. HIV-1 persistence in CD4+ T-cells with stem cell-like properties. Nat. Med. 20, 139–142 (2014).
pubmed: 24412925 pmcid: 3959167

Auteurs

Emily Adland (E)

Department of Paediatrics, University of Oxford, Oxford, UK.

Jane Millar (J)

Department of Paediatrics, University of Oxford, Oxford, UK.
HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.

Nomonde Bengu (N)

Umkhuseli Innovation and Research Management, Pietermaritzburg, South Africa.

Maximilian Muenchhoff (M)

Max von Pettenkofer Institute, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany.
German Center for Infection Research (DZIF), Partner site Munich, Munich, Germany.

Rowena Fillis (R)

Umkhuseli Innovation and Research Management, Pietermaritzburg, South Africa.

Kenneth Sprenger (K)

Umkhuseli Innovation and Research Management, Pietermaritzburg, South Africa.

Vuyokasi Ntlantsana (V)

Department of Medicine, University of KwaZulu-Natal, Durban, South Africa.

Julia Roider (J)

German Center for Infection Research (DZIF), Partner site Munich, Munich, Germany.
Department of Infectious Diseases, Ludwig-Maximilians-University, Munich, Germany.

Vinicius Vieira (V)

Department of Paediatrics, University of Oxford, Oxford, UK.

Katya Govender (K)

Africa Health Research Institute, Durban, South Africa.

John Adamson (J)

Africa Health Research Institute, Durban, South Africa.

Nelisiwe Nxele (N)

HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.

Christina Ochsenbauer (C)

Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

John Kappes (J)

Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Birmingham Veterans Affairs Medical Center, Research Service, Birmingham, AL, 35233, USA.

Luisa Mori (L)

Department of Paediatrics, University of Oxford, Oxford, UK.

Jeroen van Lobenstein (J)

Stanger Hospital, KwaDukuza, KwaZulu-Natal, South Africa.

Yeney Graza (Y)

KwaZulu-Natal Department of Health, Pietermartizburg, South Africa.

Kogielambal Chinniah (K)

Mahatma Gandhi Memorial Hospital, Phoenix, KwaZulu-Natal, South Africa.

Constant Kapongo (C)

Queen Nandi Regional Hospital, Empangeni, KwaZulu-Natal, South Africa.

Roopesh Bhoola (R)

Edendale Hospital, Pietermartizburg, KwaZulu-Natal, South Africa.

Malini Krishna (M)

Edendale Hospital, Pietermartizburg, KwaZulu-Natal, South Africa.

Philippa C Matthews (PC)

Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Ruth Penya Poderos (RP)

IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.

Marta Colomer Lluch (MC)

IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.

Maria C Puertas (MC)

IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.

Julia G Prado (JG)

IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.

Neil McKerrow (N)

KwaZulu-Natal Department of Health, Pietermartizburg, South Africa.

Moherndran Archary (M)

Department of Paediatrics, University of KwaZulu-Natal, Durban, South Africa.

Thumbi Ndung'u (T)

HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Africa Health Research Institute, Durban, South Africa.
Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.

Andreas Groll (A)

TU Dortmund University, Faculty of Statistics, Vogelpothsweg 87, 44227, Dortmund, Germany.

Pieter Jooste (P)

Department of Paediatrics, Kimberley Hospital, Northern Cape, South Africa.

Javier Martinez-Picado (J)

IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.
University of Vic-Central University of Catalonia (UVic-UCC), Catalonia, Spain.
Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

Marcus Altfeld (M)

Virus Immunology Unit, Heinrich-Pette-Institut, Hamburg, Germany.

Philip Goulder (P)

Department of Paediatrics, University of Oxford, Oxford, UK. philip.goulder@paediatrics.ox.ac.uk.
HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa. philip.goulder@paediatrics.ox.ac.uk.
Africa Health Research Institute, Durban, South Africa. philip.goulder@paediatrics.ox.ac.uk.
Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA. philip.goulder@paediatrics.ox.ac.uk.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH